AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr | ₹4,315 Cr |
What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹4,817 Cr |
Mar2023 | ₹4,466 Cr |
Mar2022 | ₹4,012 Cr |
Mar2021 | ₹3,503 Cr |
Mar2020 | ₹4,315 Cr |
How is Sundry Debtors of AUROBINDO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹4,817 Cr | 7.84 | |
Mar2023 | ₹4,466 Cr | 11.32 | |
Mar2022 | ₹4,012 Cr | 14.53 | |
Mar2021 | ₹3,503 Cr | -18.81 | |
Mar2020 | ₹4,315 Cr | - |
Compare Sundry Debtors of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,297.5 Cr | -4.2% | -7.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -4.2% |
-7.1% |
-11.6% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses